EHA 2018

Area: Hematology

Location: Stockholm, Sweden

Date: June 14 to June 17

Description:

European Hematology Association.


Search in Scientific Content:
Date
Filters:
Screening
9:47

Screening and monitoring approaches to optimise treatment in Ph+ leukaemias

Presenter: Thomas Lion
Hematology
Weekly car
5:28

Weekly carfilzomib, lenalidomide, and dexamethasone (krd) in relapsed or refractory multiple myeloma (rrmm): a phase 1b study

Presenter: Jesus G. Berdeja
Hematology
Recent dev
6:21

Recent developments in immunotherapy in AML

Presenter: Marion Subklewe
Hematology
A clinical
4:17

A clinical trial of bb2121, a second generation CAR T cell for relapsed myeloma

Presenter: Jesus G. Berdeja
Hematology
The treati
6:04

The treating FL with rituximab added to chemoimmunotherapy

Presenter: Franck Morschhauser
Hematology
The iNNOVA...
3:19

The iNNOVATE trial of rituximab with or without oral BTK-inhibitor ibrutinib to Waldenströms Macroglobulinemia

Presenter: Meletios Dimopoulos
Hematology
Highlights
7:24

Highlights of the congress

Presenter: Martina Muckenthaler
Hematology
A trial co
5:32

A trial combining a novel antibody-drug conjugate with bendamustine and rituximab for patients whose disease has returned after initial treatment

Presenter: Laurie Helen Sehn
Hematology
Introducti
8:20

Introduction to the consultation

Presenter: E Hellström Lindberg
Hematology
Marginal z
4:07

Marginal zone lymphoma: Differentiation among pathologically challenging entities

Presenter: Ponzoni Maurilio
Hematology
Current st
6:05

Current state-of-the-art therapy for diffuse large B-cell lymphoma (DLBCL) in 2018

Presenter: Christian Gisselbrecht
Hematology
A systemat
4:21

A systematic review of predictors of venous thromboembolism in acute leukemia

Presenter: Alejandro Lazo-Langner
Hematology
A final an
8:23

A final analysis of treating CLL with obinutuzumab in place of rituximab alongside chlorambucil chemotherapy

Presenter: Valentin Goede
Hematology
Mapping th
6:48

Mapping the three-dimensional genome dynamics in normal and neoplastic b cells

Presenter: José Martin-Subero
Hematology
Resolving
5:32

Resolving hematopoiesis by fate mapping and polylox barcoding

Presenter: Hans-Reimer Rodewald
Hematology
Treatment
9:20

Treatment options in second line and beyond: A case-based discussion

Presenter: Dominik Wolf
Hematology

ISTH 2021

2021-07-17 - 2021-07-21
Online, Virtual

EHA 2021

2021-06-09 - 2021-06-17
Online, Virtual

ASH 2020

2020-12-05 - 2020-12-08
Online, Virtual

EHA 2020

2020-06-11 - 2020-06-21
Online, Virtual

ESH 2020

2020-05-29 - 2020-06-01
Online, Virtual

ASH 2019

2019-12-07 - 2019-12-10
Orlando, United States

EHA 2019

2019-06-13 - 2019-06-16
Amsterdam, Netherlands

EMMA 2019

2019-01-31 - 2019-02-02
Vienna, Austria

ASH 2018

2018-12-01 - 2018-12-04
San Diego, United States